Serfaty L - Search Results

1

The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. Louvet A, et al. Among authors: serfaty l. Hepatology. 2007 Jun;45(6):1348-54. doi: 10.1002/hep.21607. Hepatology. 2007. PMID: 17518367 Clinical Trial.

2

A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.

Pelletier G, Roulot D, Davion T, Masliah C, Causse X, Oberti F, Raabe JJ, Van Lemmens C, Labadie H, Serfaty L; URSOMAF Group. Pelletier G, et al. Among authors: serfaty l. Hepatology. 2003 Apr;37(4):887-92. doi: 10.1053/jhep.2003.50118. Hepatology. 2003. PMID: 12668982 Clinical Trial.

3

Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.

Serfaty L, De Leusse A, Rosmorduc O, Desaint B, Flejou JF, Chazouilleres O, Poupon RE, Poupon R. Serfaty L, et al. Hepatology. 2003 Jul;38(1):203-9. doi: 10.1053/jhep.2003.50311. Hepatology. 2003. PMID: 12830003

4

Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.

Mathurin P, Abdelnour M, Ramond MJ, Carbonell N, Fartoux L, Serfaty L, Valla D, Poupon R, Chaput JC, Naveau S. Mathurin P, et al. Among authors: serfaty l. Hepatology. 2003 Dec;38(6):1363-9. doi: 10.1016/j.hep.2003.09.038. Hepatology. 2003. PMID: 14647046

5

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

Fartoux L, Chazouillères O, Wendum D, Poupon R, Serfaty L. Fartoux L, et al. Among authors: serfaty l. Hepatology. 2005 Jan;41(1):82-7. doi: 10.1002/hep.20519. Hepatology. 2005. PMID: 15690484

6

[Liver cirrhosis in adults: etiology and specific treatments].

Fartoux L, Serfaty L. Fartoux L, et al. Among authors: serfaty l. Rev Prat. 2005 Sep 30;55(14):1539-48. Rev Prat. 2005. PMID: 16255295 French.

7

[The irreversibility of cirrhosis: "the jostle dogma"].

Fartoux L, Pol S, Serfaty L. Fartoux L, et al. Among authors: serfaty l. Rev Prat. 2005 Sep 30;55(14):1549-51. Rev Prat. 2005. PMID: 16255296 French. No abstract available.

8

Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.

Fartoux L, Arrive L, Andreani T, Serfaty L, Chazouillères O, Tubiana JM, Poupon R, Rosmorduc O. Fartoux L, et al. Among authors: serfaty l. Gastroenterol Clin Biol. 2005 Dec;29(12):1213-9. doi: 10.1016/s0399-8320(05)82203-1. Gastroenterol Clin Biol. 2005. PMID: 16518274 Free article. Clinical Trial.

9

Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial.

Fartoux L, Degos F, Trépo C, Goria O, Calès P, Tran A, Buffet C, Poynard T, Capron D, Raabe JJ, Roulot D, Naveau S, Grange JD, Poupon RE, Poupon R, Serfaty L. Fartoux L, et al. Among authors: serfaty l. Clin Gastroenterol Hepatol. 2007 Apr;5(4):502-7. doi: 10.1016/j.cgh.2006.10.016. Epub 2007 Jan 29. Clin Gastroenterol Hepatol. 2007. PMID: 17261383 Clinical Trial.

10

[A metabolic approach to hepatitis C].

Fartoux L, Serfaty L. Fartoux L, et al. Among authors: serfaty l. Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 1):639-40. doi: 10.1016/s0399-8320(07)91910-7. Gastroenterol Clin Biol. 2007. PMID: 17925760 Free article. Review. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page